Hepatocellular carcinoma and other liver disease among greenlanders chronically infected with hepatitis B Virus: A population-based study

Journal of the National Cancer Institute

Volumn 103, Issue 22, 2011, Pages 1676-1685

  Børresen, Malene L ^a   Koch, Anders ^a   Biggar, Robert J ^a   Andersson, Mikael ^a   Wohlfahrt, Jan ^a   Ladefoged, Karin ^b   Melbye, Mads ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Dronning Ingrids Hospital   (Greenland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEPATITIS; ADULT; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; COHORT ANALYSIS; FEMALE; FOLLOW UP; GREENLAND; HEALTH SURVEY; HEPATITIS B; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SERODIAGNOSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; CONFIDENCE INTERVALS; DENMARK; FEMALE; GREENLAND; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; INUITS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POISSON DISTRIBUTION; PREVALENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 81855173450     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr405     Document Type: Article

References (84)

1. Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003;23(1):39-46. (Pubitemid 36254661)
2. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337(24):1733- 1745. (Pubitemid 27527771)
3. Fattovich G, Olivari N, Pasino M, D'Onofrio M, Martone E, Donato F. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut. 2008;57(1):84-90.
4. Duberg AS, Torner A, Davidsdottir L, et al. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat. 2008;15(7):538-550. (Pubitemid 351798992)
5. Fwu CW, Chien YC, Nelson KE, et al. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan. J Infect Dis. 2010;201(7):1016-1023.
6. Langer BC, Frosner GG, von Brunn A. Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland. J Viral Hepat. 1997;4(5):339-349. (Pubitemid 127733424)
7. Skinhoj P, McNair A, Andersen ST. Hepatitis and hepatitis B-antigen in Greenland. Am J Epidemiol. 1974;99(1):50-57.
8. Skinhoj P. Hepatitis and hepatitis B-antigen in Greenland. II: occurrence and interrelation of hepatitis B associated surface, core, and "e" antigen-antibody systems in a highly endemic area. Am J Epidemiol. 1977;105(2):99-106. (Pubitemid 8042977)
9. Gjorup IE, Smith E, Borgwardt L, Skinhoj P. Twenty-year survey of the epidemiology of hepatitis B in Denmark: effect of immigration. Scand J Infect Dis. 2003;35(4):260-264. (Pubitemid 36806036)
10. Storm HH, Nielsen NH. Cancer of the digestive system in Circumpolar Inuit. Acta Oncol. 1996;35(5):553-570. (Pubitemid 26298450)
11. Friborg J, Koch A, Wohlfahrt J, Storm HH, Melbye M. Cancer in Greenlandic Inuit 1973-1997: a cohort study. Int J Cancer. 2003;107(6):1017-1022. (Pubitemid 37429845)
12. Skinhoj P, Hart Hansen JP, Nielsen NH, Mikkelsen F. Occurrence of cirrhosis and primary liver cancer in an Eskimo population hyperendemically infected with hepatitis B virus. Am J Epidemiol. 1978;108(2):121-125. (Pubitemid 9148065)
13. Melbye M, Skinhoj P, Nielsen NH, et al. Virus-associated cancers in Greenland: frequent hepatitis B virus infection but low primary hepatocellular carcinoma incidence. J Natl Cancer Inst. 1984;73(6):1267-1272. (Pubitemid 15243567)
14. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449. (Pubitemid 44816920)
15. Misfeldt J, Jorgensen BB, Larsen SO. A serological mass examination for syphilis in Greenland in 1987. Arctic Med Res. 1988;47(4):173-178.
16. Olsen OR, Koch A, Krause TG, Barselajsen G, Christiansen CB, Melbye M. [Population screening for HIV in Sisimiut, Greenland]. Ugeskr Laeger. 2000;162(35):4652-4655.
17. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268. (Pubitemid 29299976)
18. Mosbech J, Jorgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. [The national patient registry. Evaluation of data quality]. Ugeskr Laeger. 1995;157(26):3741-3745.
19. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. 1997;44(5):535-539.
20. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol. 1988;17(1):44-49.
21. Harrel FE Jr. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analyses. New York, NY: Springer-Verlag; 2001.
22. WHO. Age-Standardized Mortality Rates by Cause (per 100 000 Population); 2001. http://www.who.int/whosis/indicators/compendium/2008/1mst/en/index.html. Accessed April 15, 2010.
23. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001;135(9):759-768. (Pubitemid 33051260)
24. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130(3):678-686. (Pubitemid 43374518)
25. Amin J, Dore GJ, O'Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol. 2006;45(2):197-203.
26. Daviethsdottir L, Duberg AS, Torner A, et al. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country. Scand J Gastroenterol. 2010;45(7-8):944-952.
27. Ribes J, Cleries R, Rubio A, et al. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer. 2006;119(3):687-694. (Pubitemid 43955725)
28. Mori M, Hara M, Wada I, et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol. 2000;151(2):131-139. (Pubitemid 30463643)
29. Simonetti J, Bulkow L, McMahon BJ, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology. 2010;51(5):1531-1537.
30. Chen JD, Yang HI, Iloeje UH, et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology. 2010;138(5):1747-1754.
31. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev. 2002;11(4):369-376. (Pubitemid 34408216)
32. Lee MS, Kim DH, Kim H, et al. Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int J Epidemiol. 1998;27(2):316-319. (Pubitemid 28203802)
33. Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis. 1984;4(2):113-121.
34. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7(6):402-409. (Pubitemid 46765200)
35. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(suppl 2):S39-S42. (Pubitemid 26167504)
36. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151(4):599-603. (Pubitemid 15102154)
37. Borresen ML, Andersson M, Wohlfahrt J, et al. Incidence of hepatitis B infection, proportion of chronic carriers and HBsAg seroclearance in Greenland. A population-based longitudinal study. 2010. Submitted.
38. Xu ZY, Francis DP, Liu CB, et al. Prevention of hepatitis B virus carriage of infants using HBV vaccine in Shanghai. Preliminary report of a randomized double-blind placebo-controlled trial. Chin Med J (Engl). 1985;98(9):623-626. (Pubitemid 16251582)
39. Kerkar N. Hepatitis B in children: complexities in management. Pediatr Transplant. 2005;9(5):685-691. (Pubitemid 41413513)
40. Borresen ML, Olsen OR, Ladefoged K, et al. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. J Viral Hepat. 2009;17(3):162-170.
41. Sakamoto T, Tanaka Y, Simonetti J, et al. Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. J Infect Dis. 2007;196(10):1487- 1492. (Pubitemid 351411985)
42. Krarup HB, Andersen S, Madsen PH, Okkels H, Hvingel BH, Laurberg P. Benign course of long-standing hepatitis B virus infection among Greenland Inuit? Scand J Gastroenterol. 2008;43(3):334-343. (Pubitemid 351238365)
43. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3(2):334-342.
44. Norder H, Courouce AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47(6):289-309. (Pubitemid 39541275)
45. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 suppl):S45-S55.
46. Livingston SE, Simonetti JP, McMahon BJ, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis. 2007;195(1):5-11. (Pubitemid 44958221)
47. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97(4):265-272.
48. Chan HL, Hui AY, Wong ML, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut. 2004;53(10):1494-1498. (Pubitemid 39265273)
49. Chan HL, Tse CH, Mo F, et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol. 2008;26(2):177-182.
50. Bjerregaard P, Curtis T, Borch-Johnsen K, et al. Inuit health in Greenland: a population survey of life style and disease in Greenland and among Inuit living in Denmark. Int J Circumpolar Health. 2003;62(suppl 1):3-79.
51. World Health Organization. Core Health Indicators. http://apps.who.int/ whosis/database/core/core-select.cfm. Indicator: Per capita recorded alcohol consumption (litres of pure alcohol) among adults (=〉15 years). Accessed November 1, 2010.
52. McMahon BJ. Viral hepatitis in the Arctic. Int J Circumpolar Health. 2004;63(suppl 2):41-48.
53. He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol. 2006;12(30):4788-4793.
54. Hohler T, Reuss E, Evers N, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet. 2002;360(9338):991-995. (Pubitemid 35284111)
55. Wu JF, Wu TC, Chen CH, et al. Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology. 2010;138(1):165-172.
56. Zhou J, Lu L, Yuen MF, et al. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J Hepatol. 2007;46(2):198-205. (Pubitemid 44959152)
57. Kim YJ, Yoon JH, Kim CY, et al. IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem Biophys Res Commun. 2006;346(1):38-44. (Pubitemid 43865966)
58. Nieters A, Yuan JM, Sun CL, et al. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer. 2005;103(4):740-748. (Pubitemid 40216402)
59. Chen CC, Yang SY, Liu CJ, et al. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol. 2005;34(6):1310-1318.
60. Thio CL, Mosbruger T, Astemborski J, et al. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol. 2005;79(14):9192-9196. (Pubitemid 40934830)
61. Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol. 2003;9(10):2221-2225. (Pubitemid 37321449)
62. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol. 1998;111(3):579-582. (Pubitemid 28160904)
63. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol. 2007;13(12):1770-1787. (Pubitemid 46706009)
64. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol. 2003;9(4):641-644.
65. Brown KS, Ryder SD, Irving WL, Sim RB, Hickling TP. Mannan binding lectin and viral hepatitis. Immunol Lett. 2007;108(1):34-44. (Pubitemid 44959061)
66. Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, Hissar S. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol. 2006;44(5):856-863.
67. Lombard Z, Dalton DL, Venter PA, Williams RC, Bornman L. Association of HLA-DR,-DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol. 2006;67(8):643-654. (Pubitemid 44205323)
68. Huang YW, Liao YT, Chen W, et al. Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan. Genes Immun. 2010;11(1):87-93.
69. Bellamy R, Ruwende C, Corrah T, et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis. 1999;179(3):721-724. (Pubitemid 30016163)
70. Welinder L, Graugaard B, Madsen M. HLA antigen and gene frequencies in Eskimos of East Greenland. Eur J Immunogenet. 2000;27(2):93-97. (Pubitemid 30213954)
71. Rasmussen M, Li Y, Lindgreen S, et al. Ancient human genome sequence of an extinct Palaeo-Eskimo. Nature. 2010;463(7282):757-762.
72. Gilbert MT, Kivisild T, Gronnow B, et al. Paleo-Eskimo mtDNA genome reveals matrilineal discontinuity in Greenland. Science. 2008;320(5884):1787- 1789. (Pubitemid 351931295)
73. Nielsen NH, Hansen JP. Lung cancer in Greenland-selected epidemiological, pathological, and clinical aspects. J Cancer Res Clin Oncol. 1982;104(3):295-305. (Pubitemid 12006269)
74. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907. (Pubitemid 47371147)
75. Kjaer SK, Nielsen NH. Cancer of the female genital tract in Circumpolar Inuit. Acta Oncol. 1996;35(5):581-587. (Pubitemid 26298453)
76. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240-2246.
77. Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol. 2007;5(8):921-931. (Pubitemid 47161142)
78. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368(9539):938-945. (Pubitemid 44331386)
79. Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study. Int J Epidemiol. 2005;34(1):132-137. (Pubitemid 40347383)
80. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582-592.
81. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med. 2004;350(11):1118-1129. (Pubitemid 38298992)
82. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med. 1990;150(5):1051-1054. (Pubitemid 20155330)
83. Parkin DM, Whelan SL, Feray L, Young J. Cancer Incidence in Five Continents. Vol VII. Lyon, France: International Agency for Research on Cancer; 1997.
84. Boysen T, Friborg J, Andersen A, Poulsen GN, Wohlfahrt J, Melbye M. The Inuit cancer pattern-the influence of migration. Int J Cancer. 2008;122(11):2568-2572. (Pubitemid 351590491)